TrialeLife2023

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).

William H K Schilling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.